Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
25%
Ph not_applicable
1
25%
Ph phase_4
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Completed1
Recruiting1
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (33.3%)
Phase 41 (33.3%)
N/A1 (33.3%)

Trials by Status

completed125%
recruiting125%
withdrawn125%
unknown125%

Recent Activity

1 active trials
Showing 4 of 4
recruitingnot_applicable

Optimization of Cardiac Resynchronization Therapy by Non-Invasive Imaging of Cardiac Electrophysiology

NCT04662970
withdrawnphase_3

CRT Improved Clinical Response UK Trial

NCT02669134
unknown

Mechanical and Electrical Dyssynchrony During His-Bundle Pacing Versus His-Bundle Area Right Ventricular Pacing

NCT04697797
completedphase_4

Evaluation of Resynchronization Therapy for Heart Failure (EARTH)

NCT00901212

Clinical Trials (4)

Showing 4 of 4 trials
NCT04662970Not Applicable

Optimization of Cardiac Resynchronization Therapy by Non-Invasive Imaging of Cardiac Electrophysiology

Recruiting
NCT02669134Phase 3

CRT Improved Clinical Response UK Trial

Withdrawn
NCT04697797

Mechanical and Electrical Dyssynchrony During His-Bundle Pacing Versus His-Bundle Area Right Ventricular Pacing

Unknown
NCT00901212Phase 4

Evaluation of Resynchronization Therapy for Heart Failure (EARTH)

Completed

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4